Home » Topics » Regulatory

Regulatory
RSS

FDA approves new combination therapy product for HCV

June 4, 1998

Novartis files for U.S. marketing approval of Sandostatin LAR

June 3, 1998

FDA advisory committee recommends expanded use of Taxotere

June 2, 1998

FDA approves Aggrastat, the first platelet blocker for unstable angina

May 22, 1998

Cor's fibrinogen antagonist on the way to market

May 19, 1998

Sanofi receives expanded approval for oxaliplatin in France

May 15, 1998

Actiq trial results published; NDA amendment filed

May 11, 1998

Serono introduces Geref for treatment/diagnosis of GHD

May 8, 1998

FDA approves improved oral contraceptive agent

May 7, 1998

FDA approves test to identify risk of preterm labor

May 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.